Effects of Sapropterin on Brain and Cognition in Individuals With Phenylketonuria
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 06 Dec 2016
At a glance
- Drugs Sapropterin (Primary)
- Indications Phenylketonuria
- Focus Pharmacodynamics
- 09 Dec 2014 Planned End Date changed from 1 Mar 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
- 09 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 10 Dec 2013 New trial record